91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

Stability Challenges III: Assuring the stability of medicines from manufacture to use

12 October 2017 10:00-16:30, London, United Kingdom


Introduction
Continuing our successful Stability Challenges series, this is an essential event for anyone concerned with the management and assessment of drug stability:
• Hear from individuals involved in the regulation and inspection of stability and GDP
• Learn from industry experts on scientific developments in stability study design and interpretation
• Debate practical issues for clinical trials and amorphous drug formulations
• Examine ways to improve compliance and productivity in stability testing
• Network with other professionals and exhibitors

You will leave this event with:
• Best practice and case studies from regulatory and industry experts
• Understanding of key developments, issues and strategies in drug stability
• Improve your stability laboratory compliance and efficiency
• New connections to experts and opinion leaders in this field
• Assure the stability of your medicines

Useful links

Speakers
  • Nigel McSweeney, Cuspor, Ireland
  • Dr Niels Hartvig Novo Nordisk, United Kingdom
  • Liselotte Kamper Novo Nordisk, United Kingdom
  • Dr Garry Scrivens, Pfizer, United Kingdom
  • Dr Samuel Kyeremateng NCE Formulation Sciences, AbbVie Deutschland GmbH, Germany
  • Dr Kristin Lehmkemper, NCE Formulation Sciences, AbbVie Deutschland GmbH, Germany

Sponsorship & supporting organisations
Royal Pharmaceutical Society and 91AV
Venue
The 91AV

The 91AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Organised by
JPAG
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*